Passamonti, F
Vannucchi, A M
Cervantes, F
Harrison, C
Morra, E
Kantarjian, H
Verstovsek, S
Article History
First Online: 24 September 2014
Competing interests
: FP participated to advisory boards of Novartis, Sanofi, Celgene, Roche. AMV received speaker honoraria and advisory board participation from Novartis; AMV institution received research support from Novartis. FC participated to Advisory Boards for Novartis, Sanofi-Aventis and Gilead and Speaker bureau of Novartis and CTI; CH participated to advisory board or received lecture honoraria from Novartis, CTI, YM Bioscience, CTI, Sanofi, Celgene, Gilead and Shire, Institutional research support from Shire and Novartis; EM and HK have no conflict of interest to declare. SV received Research support from Incyte for conducting the clinical studies.